BGM Group Ltd. (Nasdaq: BGM) (the “Company” or “BGM”) today announced completion of the...

On December19, 2024, Mr. Xin Zhanchang, Chairman of the Board of Directors of BGM Group and...

On December 13, 2024, the headquarters of BGM Group in Chengdu welcomed a distinguished visit of...

In a pivotal moment for the integration of traditional Chinese medicine into modern healthcare,...

On November 29, 2024, BGM Group Ltd. (NASDAQ: BGM) ("the Company" or "BGM") announces its...

On November 19, 2024, Qilianshan Pharmaceutical Co., Ltd. (Qilian Pharma), a subsidiary of BGM...

Licorice, with its long history of medicinal use, is renowned for its properties in tonifying the...

From October 16-18, BGM Group made its mark at the PHARMEX Excipients and Ingredients Exhibition...

BGM Group Ltd (NASDAQ: BGM) has received board approval for a 1 for 5 reverse stock split, set to...

Lanzhou, June 18, 2024 — On this special day, Mr. Xin Zhanchang, Chairman of BGM Group Ltd.,...

BGM Group Ltd (the "Company" or Nasdaq: BGM), a China-based pharmaceutical and chemical products...